LPA anticorps
-
- Antigène Voir toutes LPA (APOA) Anticorps
- LPA (APOA) (Apolipoprotein A (APOA))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp LPA est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Purification
- purified
- Immunogène
- Purified recombinant fragment of LPA (4330-4521) expressed in E. coli.
- Clone
- 8F6A9
- Isotype
- IgG1
- Top Product
- Discover our top product APOA Anticorps primaire
-
-
- Indications d'application
- ELISA: 1:10000, WB: 1:500 - 1:2000, IHC: 1:200 - 1:1000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Ascitic fluid containing 0.03 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- 4°C, -20°C for long term storage
-
-
Effect of aspirin on lipoprotein(a) in patients with ischemic stroke." dans: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, Vol. 16, Issue 5, pp. 220-4, (2007) (PubMed).
: "The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease." dans: Clinica chimica acta; international journal of clinical chemistry, Vol. 387, Issue 1-2, pp. 109-12, (2007) (PubMed).
: "
-
Effect of aspirin on lipoprotein(a) in patients with ischemic stroke." dans: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, Vol. 16, Issue 5, pp. 220-4, (2007) (PubMed).
-
- Antigène
- LPA (APOA) (Apolipoprotein A (APOA))
- Autre désignation
- LPA (APOA Produits)
- Synonymes
- anticorps AK38, anticorps APOA, anticorps LP, anticorps Apo(a), anticorps Lp(a), anticorps lipoprotein(a), anticorps LPA
- Sujet
-
Description: LPA: lipoprotein, Lp(a). Apo(a) is the main constituent of lipoprotein(a) (lp(a)). It has serine proteinase activity and is able of autoproteolysis. Inhibits tissue-type plasminogen activator 1.Lp(a) may be a ligand for megalin/gp 330.Apo(a) is known to be proteolytically cleaved, leading to the formation of the so-called mini-lp(a).Apo(a) fragments accumulate in atherosclerotic lesions,where they may promote thrombogenesis.O-glycosylation may limit the extent of proteolytic fragmentation.
Aliases: LP, AK38, APOA, LPA
- ID gène
- 4018
- HGNC
- 4018
-